Search

Search Constraints

You searched for: Author/Creator Porchet, Hervé

Search Results

1. A new therapeutic approach for type 1 diabetes: Rationale for GNbAC1, an anti‐HERV‐W‐Env monoclonal antibody. Issue 9 (10th June 2018)

2. A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients. (June 2015)

3. A safety and pharmacodynamics study of temelimab, an antipathogenic human endogenous retrovirus type W envelope monoclonal antibody, in patients with type 1 diabetes. Issue 7 (12th March 2020)

4. Efficacy and safety of temelimab in multiple sclerosis: Results of a randomized phase 2b and extension study. (March 2022)